- Approval Id
- a968d57a1d00f4ab
- Drug Name
- FAMOTIDINE FILM COATED TABLET 20 MG
- Product Name
- FAMOTIDINE FILM COATED TABLET 20 MG
- Approval Number
- SIN10210P
- Approval Date
- 1998-10-08
- Registrant
- GOLDPLUS UNIVERSAL PTE LTD
- Licence Holder
- GOLDPLUS UNIVERSAL PTE LTD
- Drug Type
- Therapeutic
- Forensic Classification
- PRESCRIPTION ONLY MEDICINES
- Dosage Form
- TABLET, FILM COATED
- Dosage
- <p><strong>DOSAGE & ADMINISTRATION</strong><br>
<strong>Usual adult and adolescent dose:</strong><br>
<strong><u>Duodenal ulcer:</u></strong> Oral, 40 mg once daily at bedtime or 20 mg 2 times daily.<br>
<strong><u>Prophylaxis of recurrent duodenal ulcer:</u></strong> Oral, 20 mg at bedtime.<br>
<strong><u>Gastric ulcer:</u></strong> Oral, 40 mg once daily at bedtime.<br>
<strong><u>Gastric hypersecretory conditions (eg. Zollinger-Ellison syndrome):</u></strong> Oral, 20 mg every 6 hours, the dosage being adjusted as needed and therapy continued for as long as clinically indicated. Doses up to 160 mg every 6 hours have been administered to some patients with severe Zollinger-Ellison syndrome.<br>
<strong><u>Gastro-oesophageal reflux:</u></strong> Oral, 20 mg 2 times daily for up to 6 weeks. The recommended oral dose for oesophagitis due to gastro-oesophageal reflux disease is 20 to 40 mg 2 times daily for up to 12 weeks.<br>
<strong><u>Dosage Adjustment for patients with moderate to severe renal insufficiency:</u></strong> In adult patients with moderate (creatinine clearance < 50 mL/min) or severe (creatinine clearance < 10mL/min) renal insufficiency, the dose of Famotidine may be reduced to half the dose or the dosing interval may be prolonged to 36–48 hours as indicated by patient's clinical response.</p>
<p>Note: The information given here is limited. For further information, please consult your doctor or pharmacist.</p>
- Route Of Administration
- ORAL
- Indication Info
- <p><strong>INDICATIONS</strong><br>
Famotidine is indicated in the short term treatment of duodenal ulcer, benign gastric ulcer and hypersecretory conditions such as Zollinger-Ellison syndrome. It is also used in the prevention of relapses of duodenal ulceration, symptomatic relief of gastro-oesophageal reflux disease and healing of oesophageal erosions or ulceration associated with gastro-oesophageal reflux disease.</p>
- Contraindications
- <p><strong>CONTRAINDICATIONS</strong><br>
Risk-benefit should be considered when the following medical problems exist:</p>
<ul>
<li>Cirrhosis</li>
<li>Hepatic and renal function impairment</li>
<li>Sensitivity to any of the histamine H<sub>2</sub>-receptor antagonists</li>
</ul>
- Atc Code
- A02BA03
- Atc Item Name
- famotidine
- Pharma Manufacturer Name
- GOLDPLUS UNIVERSAL PTE LTD
